Search
Search Results
##search.searchResults.foundPlural##
-
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1316PDF: 967HTML: 314 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6599PDF: 2288HTML: 14187Untitled: 270figure: 244 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3884PDF: 1325HTML: 1676 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2442PDF: 969HTML: 2038Fig 1 Rossi: 266 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2524PDF: 824HTML: 2160Untitled: 311Untitled: 206Untitled: 246Untitled: 223Untitled: 249Untitled: 260Untitled: 254 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
900PDF: 609HTML: 4056 -
WHAT ARE FUNGAL INFECTIONS?
4480PDF: 2559HTML: 27723de Pauw: 313 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2214PDF: 193HTML: 53 -
OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
4810PDF: 1312HTML: 517Figure: 299 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4747PDF: 1611HTML: 8568 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
810PDF: 517HTML: 6299 -
CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA
2838PDF: 1043HTML: 3744 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2384PDF: 2050HTML: 547 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2778PDF: 966HTML: 17631Fig1 Caligaris: 259Fig.2 Caliga: 287 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1844PDF: 593MP4: 512Html: 327 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1359PDF: 871HTML: 270 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2970PDF: 1067HTML: 4763 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2734PDF: 1049HTML: 400 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
955PDF: 538HTML: 1333 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2954PDF: 1214HTML: 2708 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2074PDF: 1275HTML: 358 -
-
-
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1816PDF: 908HTML: 977cover letter: 391 -
COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia
1088PDF: 787HTML: 172 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4508PDF: 1634HTML: 498 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2291PDF: 928HTML: 1661Figure 1: 630







